The reasons for the poor prognosis in young women with breast cancer are complex, the most important being the more aggressive nature of it, including a high proportion of triple-negative, human epidermal growth factor receptor 2 (HER2) overexpression, grade 3, lymphovascular invasion, and lymphocytic infiltration (7). Here, ERBB2 is linked to breast carcinoma.